Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1:500-1:1000 |
1:100-1:200 |
1:200 |
Assay dependent |
Not tested in other applications.
Product Note
This antibody reacted with HA protein of most of Influenza B virus isolates belonging to Victoria group tested (70/73 strains) and none of clinical 27 isolates belonging to Yamagata group as examined by PAP staining. However later test with IF staining it also reacts with some of Yamagata group strains like B/Florida/4/2006. However, note that HA changes during passages and may change reactivity to this antibody.
We do not recommend use of this product for Influenza A virus samples.
Form
Liquid
Buffer
Filter-sterilized PBS, 50% Glycerol
Preservative
No preservative
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Influenza B virus
Immunogen
Human Influenza B Virus strain Nagasaki/1/87, one of the strains of B/Victoria group
Purification
Purified IgG
From culture supernant
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.